Seres Therapeutics (MCRB) Current Leases (2019 - 2025)
Historic Current Leases for Seres Therapeutics (MCRB) over the last 7 years, with Q3 2025 value amounting to $9.9 million.
- Seres Therapeutics' Current Leases rose 1885.93% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 1885.93%. This contributed to the annual value of $8.7 million for FY2024, which is 5525.33% up from last year.
- According to the latest figures from Q3 2025, Seres Therapeutics' Current Leases is $9.9 million, which was up 1885.93% from $9.5 million recorded in Q2 2025.
- Seres Therapeutics' Current Leases' 5-year high stood at $9.9 million during Q3 2025, with a 5-year trough of $3.6 million in Q4 2022.
- Over the past 5 years, Seres Therapeutics' median Current Leases value was $6.8 million (recorded in 2022), while the average stood at $7.1 million.
- In the last 5 years, Seres Therapeutics' Current Leases plummeted by 4552.19% in 2022 and then skyrocketed by 8463.63% in 2024.
- Quarter analysis of 5 years shows Seres Therapeutics' Current Leases stood at $6.6 million in 2021, then plummeted by 45.52% to $3.6 million in 2022, then soared by 55.15% to $5.6 million in 2023, then soared by 55.25% to $8.7 million in 2024, then rose by 14.36% to $9.9 million in 2025.
- Its Current Leases was $9.9 million in Q3 2025, compared to $9.5 million in Q2 2025 and $9.0 million in Q1 2025.